Invesco Nasdaq Biotechnology ETF Rating $29.14 +0.69 (+2.43%) As of 04:00 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOptions ChainOwnershipRatingsShort InterestTrendsBuy This Stock Invesco Nasdaq Biotechnology ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.IBBQ Aggregate RatingModerate Buy 2.73Holdings in IBBQ have an aggregate rating of Moderate Buy based on 517 analyst ratings issued in the past year covering 25 companies (61.5% of the portfolio).IBBQ Aggregate Price Target$29.100.07% UpsideHigh Prediction$29.10Average Prediction$29.10Low Prediction$29.10Holdings in IBBQ have an aggregate price target of $29.10 and a range of $29.10 to $29.10 covering 25 companies (61.5% of the portfolio).IBBQ Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy3 Buy rating(s)Moderate Buy16 Moderate Buy rating(s)Hold5 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Invesco Nasdaq Biotechnology ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 IBBQ Holdings ExportWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings7.55%VRTXVertex Pharmaceuticals$430.44-0.9%4.5535 of 5 stars2.88$555.17 29.0%26Positive NewsAnalyst UpgradeAnalyst Revision7.48%GILDGilead Sciences$130.69+0.1%4.7838 of 5 stars2.86$156.93 20.1%29Trending NewsAnalyst ForecastInsider TradeAnalyst Revision7.18%AMGNAmgen$331.57+0.2%3.9688 of 5 stars2.48$355.19 7.1%31Positive NewsAnalyst Forecast5.46%REGNRegeneron Pharmaceuticals$649.76+3.1%4.4515 of 5 stars2.70$792.65 22.0%27Trending NewsAnalyst Forecast3.17%ALNYAlnylam Pharmaceuticals$298.48+1.4%4.6739 of 5 stars2.85$463.13 55.2%26News CoveragePositive NewsAnalyst Upgrade2.39%RVMDRevolution Medicines$150.33+2.1%2.4963 of 5 stars3.05$108.88 -27.6%20Analyst Forecast2.35%BIIBBiogen$187.80-1.4%4.1839 of 5 stars2.52$215.62 14.8%292.07%UTHRUnited Therapeutics$563.93-0.5%3.5746 of 5 stars2.85$619.42 9.8%13Insider TradeAnalyst Revision1.93%INSMInsmed$107.91+0.5%3.5073 of 5 stars2.96$210.95 95.5%25Positive News1.86%RPRXRoyalty Pharma$53.06+1.2%3.9845 of 5 stars3.00$53.71 1.2%71.84%ARGXargenex$804.25+0.8%4.5572 of 5 stars2.92$1,017.78 26.5%241.81%ILMNIllumina$141.92+0.2%3.1999 of 5 stars2.28$137.75 -2.9%181.71%ROIVRoivant Sciences$32.41+14.9%2.0954 of 5 stars2.75$30.55 -5.7%12Trending NewsEarnings ReportOptions VolumeGap UpHigh Trading Volume1.59%MRNAModerna$48.12+5.2%1.3256 of 5 stars1.84$35.73 -25.7%19Insider TradeGap Up1.59%VTRSViatris$16.59+2.6%2.5373 of 5 stars2.38$16.43 -1.0%8Analyst Forecast1.58%INCYIncyte$97.08+1.5%4.5845 of 5 stars2.43$104.26 7.4%21Positive News1.32%NBIXNeurocrine Biosciences$154.67+0.2%3.9429 of 5 stars2.82$184.15 19.1%22Insider Trade1.22%ASNDAscendis Pharma A/S$241.34+1.4%3.9071 of 5 stars3.00$295.39 22.4%19Analyst Upgrade1.18%JAZZJazz Pharmaceuticals$239.01+0.7%2.8582 of 5 stars2.89$238.00 -0.4%18Analyst Upgrade1.08%EXELExelixis$49.90+2.5%2.7123 of 5 stars2.39$47.35 -5.1%23Trending NewsInsider Trade1.06%BBIOBridgeBio Pharma$68.22+3.4%3.6687 of 5 stars2.88$88.90 30.3%25Analyst ForecastInsider Trade1.05%GHGuardant Health$114.97+17.1%2.5752 of 5 stars2.86$129.42 12.6%21Gap UpHigh Trading Volume1.04%SMMTSummit Therapeutics$17.89+12.9%2.7657 of 5 stars2.50$27.58 54.2%16Analyst DowngradeOptions Volume1.00%MDGLMadrigal Pharmaceuticals$513.47+0.3%2.8386 of 5 stars2.76$687.00 33.8%17Insider Trade1.00%IONSIonis Pharmaceuticals$75.06+1.7%3.4372 of 5 stars2.90$100.90 34.4%21Analyst Upgrade This page (NASDAQ:IBBQ) was last updated on 5/20/2026 by MarketBeat.com Staff. From Our PartnersTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredYour $29.97 book is free todayWhy Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...Profits Run | SponsoredIran's New Leader Just Said Something That Should Terrify Every AmericanIran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...American Alternative | SponsoredHey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...Banyan Hill Publishing | SponsoredI’m sounding the alarmMeta is cutting 10% of its workforce. Microsoft offered voluntary retirement to 7% of U.S. employees. Oracle, ...Porter & Company | SponsoredTrump Is Eyeing the Biggest Monetary Shift Since NixonOn August 15, 1971, Nixon ended the Bretton Woods agreement and untethered the dollar from gold. Since that ni...Americas Gold Company | SponsoredFed story no one is tellingJ.P. Morgan's Private Bank quietly advised 333 billionaire families to move 60% of their portfolios into alter...TradeSmith | SponsoredOne page of the SpaceX S-1 will move this stock overnightWhen SpaceX files its S-1 in June, the SEC will require full disclosure of operating expenses - including powe...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Invesco Nasdaq Biotechnology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Invesco Nasdaq Biotechnology ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
